Post Reply
61-80 of 88
UltraGreen.ai gets regulatory approval for its products in Malaysia and the Philippines
This facilitates the company&rsquo s delivery of surgical technologies to healthcare systems in South-east Asia, UltraGreen.ai says
[SINGAPORE] Surgical technology firm UltraGreen.ai has secured dual market regulatory approvals for two of its products less than a month since its trading debut on the Singapore Exchange.
It clinched approvals for Verdye, a fluorescence dye used in fluorescence-guided surgery, in the Philippines.
It also secured approval for IC-Flow Imaging System V2 &ndash a medical infrared camera system that captures fluorescent images in surgical procedures, in Malaysia.
On Tuesday (Dec 30), the company said the approvals mark an &ldquo important step&rdquo in its strategic expansion across South-east Asia, where healthcare demand is growing.
This comes as UltraGreen.ai aims to expand the use of fluorescence-guided surgery &ndash which has become an increasingly important tool across surgical procedures and specialties &ndash in the region.
Declan Cassells, chief operating officer of UltraGreen.ai, said that the approvals will facilitate the company&rsquo s delivery of surgical technologies to healthcare systems across the South-east Asia.
&ldquo With these approvals in place, UltraGreen.ai and its local partners can now actively support education, training and broader clinical adoption of indocyanine green-based techniques among surgeons in both markets,&rdquo the company said.
Beyond regulatory approvals, the company said that it is growing its footprint in the region via clinical partnerships and market access initiatives.
Quek Mei Ling, chief business officer for Asia-Pacific at UltraGreen.ai, noted that the approvals come as South-east Asia is experiencing a rise in surgical procedures across oncology, colorectal and reconstructive care.
2 IDs did insider purchases and Mr Hsieh is a very known individual who bought at $1.39 and $1.44 - about time for the stock to go back to IPO price now that it has stabilised?
Q 1.39 try try to average
Can buy at $1.32? Its sellers market.
UltraGreen ID Hsieh Fu Hua buys more shares stabilising action completed
Hsieh Fu Hua, an independent director of newly-listed UltraGreen.ai, has again bought more shares of the company.
On Dec 12, Hsieh, a former CEO of SGX, paid US$1.44 each for 120,000 shares.
This brings his total holdings to 300,000 shares. He first bought the company' s shares on Dec 9, paying US$1.39 each.
In a separate announcement, co-manager of the IPO, Citibank, had on Dec 12 bought 1,519,700 shares, as part of its latest stabilising action.
The shares were bought at between US$1.43 to US$1.45.
With this, the IPO managers have bought all 20,689,700 shares as part of the post-listing stabilisation mandate, and that the over-allotment option will not be exercised.
Its IPO two weeks ago was priced at US$1.45.
looking for profit
Sgvale ( Date: 11-Dec-2025 10:34) Posted:
|
Metaoptics took advantage of the homegrown company image n garner G pawns support. Ultragreen on other hand did not. If they did, they would hv surge like u said. But tbh, I wouldn't. If the company is solid, it's better not to do that just to reap the short term outcomes. Just take a look at yzjsb and yzjf (before splitting).
You take a closer look at metaoptics trading volume last week ago n u will know. Trade volumes are about or less than 1.5 million shares daily but price went up by about 50%. This is the pawns at work.
Sgvale ( Date: 09-Dec-2025 10:07) Posted:
|
This is different from metaoptics, which only has the support of G pawns and currently has no real customers. Also, ultragreen has significant market dominance over the supply of the dyes used in biomedical applications. FYI, hospitals and biomedical agencies usually like to stick to established dyes.
Sgvale ( Date: 09-Dec-2025 09:40) Posted:
|
I still hold on my ipo 1,000 shares :)
superstartup ( Date: 08-Dec-2025 16:11) Posted:
|
This is actually quite funny.. 🤣
superstartup ( Date: 08-Dec-2025 16:11) Posted:
|
Had cut this UltraRed.
Decided to move on.
Decided to move on.
Thank shortists will short until technical rebound. Trade with care.
IPO got stablasing manager type usually submarine .....
why this company calls itself AI?
it just sells some reagents for use in some surgeries, right?
it just sells some reagents for use in some surgeries, right?
Some of the pre-IPO folks taking money off the table? Quite disappointing post listing performance after a strong 1st day...
We only understand when price go up rest is history.... money in not red colour out lah.
investshare ( Date: 04-Dec-2025 20:21) Posted:
|
STABILISING ACTION IN RELATION TO THE INITIAL PUBLIC OFFERING (THE " OFFERING" ) OF ORDINARY SHARES (" SHARES" ) IN ULTRAGREEN.AI LIMITED
Date of Purchases: 4 December 2025
Total Number of Shares Purchased: 1,820,000 shares
Price Range of Purchases: US$1.45
Total Number of Shares Purchased: 1,820,000 shares
Price Range of Purchases: US$1.45
I think retailer does not understand it.
Wait for AI theme fund manager to come in.
Wait for AI theme fund manager to come in.
Also so fast no forumer heed this stock almost half day no post already ...
ysh2006 ( Date: 04-Dec-2025 12:58) Posted:
|